B.I. South Africa (Pty.) Ltd.   Report issue

For profit Phase 3 Phase 4
Founded: Gauteng South Africa (1982)
Status: No NME R&D (1982)

Organization Overview

First Clinical Trial
2002
NCT00273975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

HIV Infections (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Pharyngitis (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7